• 1
    Zheng L, Walters EH, Ward C et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplant. Thorax 2000; 55: 5360.
  • 2
    Ward C, Snell GI, Zheng L et al. A cross sectional comparison of endobronchial biopsy and bronchoalveolar lavage: clinically stable lung allograft recipients versus recipients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1998; 158: 8491.
  • 3
    DiGiovine B, Lynch III JP, Martinez FJ et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation. J Immunol 1996; 157: 41944202.
  • 4
    Riise GC, Andersson BA, Kjellstrom C et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 1999; 14: 11231130.
  • 5
    Tiroke AH, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant 1999; 13: 131157.
  • 6
    Devouassoux G, Drouet C, Pin I et al. Grenoble Lung Transplant Group. Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity. Transplant Immunology 2002; 10: 303310.
  • 7
    Henke JA, Golden JA, Yelin EH, Keith FA, Blanc PD. Persistent increases in BAL neutrophilia as a predictor of mortality following lung transplantation. Chest 1999; 115: 403409.
  • 8
    Hirsch J, Elssner A, Mazur G et al. Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity. Am J Respir Crit Care Med 1999; 160: 16401646.
  • 9
    Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000; 161: 19241929.
  • 10
    Slebos DJ, Postma DS, Koeter GH, Van Der Bij W, Boezen M, Kauffman HF. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection. J Heart Lung Transplant 2004; 23: 532540.
  • 11
    Snell GI, Ward C, Wilson JW, Orsida B, Williams TJ, Walters EH. Immunopathological changes in the airways of stable lung transplant recipients. Thorax 1997; 52: 322328.
  • 12
    Jeffery PK. The value of bronchial biopsies: assessment of inflammation in asthma and COPD. Eur Respir Rev 1998; 8: 10791085.
  • 13
    O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopses of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155: 852857.
  • 14
    Rutgers SR, Postma DS, Ten-Hacken NH et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55: 1218.
  • 15
    Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002; 21: 297310.
  • 16
    Snell GI, Hall M, Esmore DS, Williams TJ. Cytolytic therapy for obliterative bronchiolitis complicating lung transplantation. Chest 1996; 109: 874879.
  • 17
    Zheng L, Orsida B, Whitford H et al. Longitudinal comparisons of lymphocytes and sub-types between airway wall and bronchoalveolar lavage after human lung transplantation. Transplantation 2005; 80: 185193.
  • 18
    Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 115.
  • 19
    Chakinala MM, Trulock EP. Acute allograft rejection after lung transplantation: diagnosis and therapy. Chest Surg Clin N Am 2003; 13: 525531.
  • 20
    Laan M, Cui ZH, Hoshino H et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162: 23472352.
  • 21
    Westall G, Kotsimbos T. Cytomegaloviral infection and other infections related to lung allograft survival. Curr Opin Organ Transpl 2004; 9: 342349.
  • 22
    Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 2003; 75: 20642068.
  • 23
    Kotsimbos TC, Snell GI, Levvey B et al. Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2005; 79: 269275.
  • 24
    Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118: 15571565.
  • 25
    Saba S, Soong G, Creaky S, Prince A. Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol 2002; 27: 561567.
  • 26
    O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopses of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155: 852857.
  • 27
    Di-Stefano A, Capelli A, Lusuardi M et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158: 12771285.
  • 28
    Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin ED. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. Ann Intern Med 1987: 107: 300304.
  • 29
    Strieter RM, Standiford TJ, Rolfe MW, Kunkel SK. Interleukin-8. In: KelleyJ, ed. Cytokines of the Lung. Marcel Dekker, Inc. New York 1992: 281305.